Ignite Creation Date:
2025-12-24 @ 10:06 PM
Ignite Modification Date:
2025-12-26 @ 5:30 PM
Study NCT ID:
NCT03099135
Status:
TERMINATED
Last Update Posted:
2025-02-03
First Post:
2017-03-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Long Term Follow-up Study in Participants Treated in a Preceding Phase 2 or 3 Study With a Regimen Containing Odalasvir and AL-335 With or Without Simeprevir for the Treatment of Hepatitis C Virus (HCV) Infection
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-10
Start Date Type:
ACTUAL
Primary Completion Date:
2018-02-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-02-13
Completion Date Type:
ACTUAL
First Submit Date:
2017-03-30
First Submit QC Date:
None
Study First Post Date:
2017-04-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-31
Last Update Post Date:
2025-02-03
Last Update Post Date Type:
ACTUAL